Skip to main content
Explore URMC

Golisano Children's Hospital Logo

menu

Current Projects

Current projects in the division include:

  • A Phase 4, Open-Label, Prospective Study in Patients with Pompe Disease to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale.  Sponsored by Genzyme Corporation. (PI: Fong)
  • New York State Genetics Screening and Counseling Program. (PI: Fong)
  • Inborn Errors of Metabolism Information System (IBEM-IS) grant from New-York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services (NYMAC). (PI: Fong)
  • Principal Investigator, PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes and Safety Registry from BioMarin Pharmaceuticals (NCT00778206). (PI: Fong)